NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Institute of Medicine (US) Committee on Reviewing the HIVNET 012 Perinatal HIV Prevention Study. Review of the HIVNET 012 Perinatal HIV Prevention Study. Washington (DC): National Academies Press (US); 2005.
Review of the HIVNET 012 Perinatal HIV Prevention Study.
Show detailsMeeting One. September 30, 2004
The National Academy of Sciences Building
2100 C St., N.W., Board Room
Washington, D.C.
| 8:45-9:15 a.m. | Registration |
| 9:15-9:30 a.m. | Welcome, Introductions, and Opening Statement
Stephen Lagakos, Ph.D. IOM Committee Member |
| 9:30-9:45 a.m. | Charge to the Committee (via phone)
Ruth Kirschstein, M.D. Senior Advisor to the Director National Institutes of Health |
| 9:45-10:00 a.m. | Questions from the Committee |
| 10:00-10:45 a.m. | Overview of HIVNET 012 Trial
J. Brooks Jackson, M.D., M.B.A. HIVNET 012 Principal Investigator Johns Hopkins University |
Laura Guay, M.D. HIVNET 012 Co-Investigator Johns Hopkins University | |
Tom Fleming, Ph.D. HIVNET 012 Co-Investigator University of Washington | |
| 10:45-11:15 a.m. | Questions from the Committee |
| 11:15-11:45 a.m. | Review of Perinatal HIV Prevention Trials Involving Nevirapine: Safety and Efficacy Data
Lynne Mofenson, M.D. Pediatric, Adolescent and Maternal AIDS Branch Center for Research for Mothers and Children National Institute of Child Health and Human Development National Institutes of Health |
| 11:45 a.m.-12:00 | Questions from the Committee |
| 12:00-1:00 p.m. | Lunch |
| 1:00-1:30 p.m. | NIH Remonitoring Study of HIVNET 012
John LaMontagne, Ph.D. Deputy Director National Institute of Allergy and Infectious Diseases National Institutes of Health |
| 1:30-2:00 p.m. | Questions from the Committee |
| 2:00-2:45 p.m. | Comments from HIVNET 012 Investigators on NIH Remonitoring Study
J. Brooks Jackson, M.D., M.B.A. HIVNET 012 Principal Investigator Johns Hopkins University |
Laura Guay, M.D. HIVNET 012 Co-Investigator Johns Hopkins University | |
Tom Fleming, Ph.D. HIVNET 012 Co-Investigator University of Washington | |
| 2:45-3:15 p.m. | Questions from the Committee |
| 3:15-3:55 p.m. | Public Comment Period |
| 3:55-4:00 p.m. | Closing Remarks
Stephen Lagakos, Ph.D. IOM Committee Member |
| 4:00 p.m. | Adjourn |
Meeting Three. January 4, 2005
Keck Center of the National Academies
500 Fifth Street, N.W., Room 201
Washington, DC
| 10:00-10:05 a.m. | Opening Remarks
James Ware, Ph.D. IOM Committee Chair |
| 10:05-10:45 a.m. | Comments on the HIVNET 012 Perinatal HIV Prevention Trial
Jonathan Fishbein, M.D. (Former Director of Office for Policy in Clinical Research Operations, Division of AIDS, NIAID, NIH) |
| 10:45-11:15 a.m. | Questions from the committee |
- Agendas of Information-Gathering Meetings - Review of the HIVNET 012 Perinatal H...Agendas of Information-Gathering Meetings - Review of the HIVNET 012 Perinatal HIV Prevention Study
- Profile neighbors for GEO Profiles (Select 126706900) (199)GEO Profiles
- Gene Links for GEO Profiles (Select 126710995) (2)Gene
- OMIM Links for GEO Profiles (Select 101969940) (3)OMIM
- GRHL3-depleted epidermal keratinocyte response to the induction of differentiati...GRHL3-depleted epidermal keratinocyte response to the induction of differentiation in vitroAccession: GDS5453GEO DataSets
Your browsing activity is empty.
Activity recording is turned off.
See more...